Viewing Study NCT01314833


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-09 @ 2:19 AM
Study NCT ID: NCT01314833
Status: COMPLETED
Last Update Posted: 2020-05-19
First Post: 2011-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Luminal A View
None Luminal B View
None TNBC View
None DFS View
None DDFS View
None OS View